Publicacions en què col·labora amb Enrique Ortega Forte (16)

2024

  1. A Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent

    ACS Applied Materials and Interfaces, Vol. 16, Núm. 30, pp. 38916-38930

  2. Photoactivatable Ruthenium Complexes Containing Minimal Straining Benzothiazolyl-1,2,3-triazole Chelators for Cancer Treatment

    Inorganic Chemistry, Vol. 63, Núm. 14, pp. 6202-6216

2023

  1. A near-infrared light-activatable Ru(ii)-coumarin photosensitizer active under hypoxic conditions

    Chemical Science, Vol. 14, Núm. 26, pp. 7170-7184

  2. Exploring Structure-Activity Relationships in Photodynamic Therapy Anticancer Agents Based on Ir(III)-COUPY Conjugates

    Journal of Medicinal Chemistry, Vol. 66, Núm. 12, pp. 7849-7867

  3. Newly synthesized benzothiazolyl-1,2,3-triazole derivatives: Intramolecular charge transfer tuning, solvatofluorochromism and antiproliferative properties

    Dyes and Pigments, Vol. 209

2022

  1. Improving Photodynamic Therapy Anticancer Activity of a Mitochondria-Targeted Coumarin Photosensitizer Using a Polyurethane-Polyurea Hybrid Nanocarrier

    Biomacromolecules, Vol. 23, Núm. 7, pp. 2900-2913

  2. Polyurethane-polyurea hybrid nanocapsules as efficient delivery systems of anticancer Ir(iii) metallodrugs

    Inorganic Chemistry Frontiers

  3. Potent anticancer activity of a novel iridium metallodrug via oncosis

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 10

2021

  1. A 2-(benzothiazol-2-yl)-phenolato platinum(II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy†

    European Journal of Medicinal Chemistry, Vol. 222

  2. COUPY Coumarins as Novel Mitochondria-Targeted Photodynamic Therapy Anticancer Agents

    Journal of Medicinal Chemistry, Vol. 64, Núm. 23, pp. 17209-17220

  3. Novel organo-osmium(ii) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth in: Caenorhabditis elegans

    Inorganic Chemistry Frontiers, Vol. 8, Núm. 1, pp. 141-155

  4. Targeting translation: a promising strategy for anticancer metallodrugs

    Coordination Chemistry Reviews, Vol. 446

2020

  1. An Erlotinib gold(I) conjugate for combating triple-negative breast cancer

    Journal of Inorganic Biochemistry, Vol. 203

  2. Ru(ii) photosensitizers competent for hypoxic cancersviagreen light activation

    Chemical Communications, Vol. 56, Núm. 71, pp. 10301-10304

2019

  1. Luminescent Gold(I) Complexes of 1-Pyridyl-3-anthracenylchalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects

    Inorganic Chemistry, Vol. 58, Núm. 19, pp. 12954-12963

2018

  1. A new C,N-cyclometalated osmium(ii) arene anticancer scaffold with a handle for functionalization and antioxidative properties

    Chemical Communications, Vol. 54, Núm. 79, pp. 11120-11123